These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 957503)

  • 21. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Black Tea Consumption on Urinary Risk Factors for Kidney Stone Formation.
    Siener R; Hesse A
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cranberry juice consumption on urinary stone risk factors.
    Gettman MT; Ogan K; Brinkley LJ; Adams-Huet B; Pak CY; Pearle MS
    J Urol; 2005 Aug; 174(2):590-4; quiz 801. PubMed ID: 16006907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers.
    Trinchieri A; Lizzano R; Marchesotti F; Zanetti G
    Urol Res; 2006 Feb; 34(1):1-7. PubMed ID: 16425021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
    Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the associations between urinary excretion of magnesium and that of other components in calcium stone-forming patients.
    Tavasoli S; Taheri M; Taheri F; Basiri A; Bagheri Amiri F
    Int Urol Nephrol; 2019 Feb; 51(2):279-284. PubMed ID: 30515733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The urinary excretion and serum concentration of calcium, magnesium, sodium and phosphate in male patients with recurring renal stone formation.
    Jorgensen FS
    Scand J Urol Nephrol; 1975; 9(3):243-8. PubMed ID: 1209181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary excretion of urate in renal calcium stone disease and in renal tubular acidification disturbances.
    Fellström B; Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström B
    J Urol; 1982 Mar; 127(3):589-92. PubMed ID: 7062444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of allopurinol action in calcium oxalate stone formers.
    Tomlinson B; Al-Khader A; Cohen SL; Kasidas GP; Krywawych S; Edgar L; Rose GA
    Proc Eur Dial Transplant Assoc; 1981; 18():556-60. PubMed ID: 6276882
    [No Abstract]   [Full Text] [Related]  

  • 34. Urate metabolism in primary hyperparathyroidism.
    Ljunghall S; Akerström G
    Urol Int; 1982; 37(2):73-8. PubMed ID: 7112764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of magnesium hydroxide in renal stone disease.
    Johansson G; Backman U; Danielson BG; Fellström B; Ljunghall S; Wikström B
    J Am Coll Nutr; 1982; 1(2):179-85. PubMed ID: 6764473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Short-term effect of thiazides on magnesium and calcium metabolism and secondarily on that of phosphorus, uric acid, oxalate and cyclic AMP].
    Hodler J; Roulin F; Haldimann B
    Nephrologie; 1983; 4(2):60-3. PubMed ID: 6308488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnesium metabolism in renal stone disease.
    Johansson G; Backman U; Danielson BG; Ljunghall S; Wikström B
    Invest Urol; 1980 Sep; 18(2):93-6. PubMed ID: 7410037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrolithiasis: current concepts in medical management.
    Pahira JJ
    Urol Radiol; 1984; 6(2):74-9. PubMed ID: 6377648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.